Key points are not available for this paper at this time.
A series of hetero- and homometallic square complexes bridged by a photoactive 4,4'-azopyridine (AZP) or 1,2-bis(4-pyridyl)ethylene (BPE) ligand, cyclobis[cis-(dppf)M(mu-L)(2)(fac-Re(CO)(3)Br)](OTf)(4) (M = Pd, L = trans-AZP (5); M = Pt, L = trans-AZP (7); M = Pd, L = trans-BPE (8); M = Pt, L = trans-BPE (10)), cyclo[cis-(dppf)M(mu-L)(2)(fac-Re(CO)(3)Br)](OTf)(2) (M = Pd, L = cis-AZP (6); M = Pd, L = cis-BPE (9)), cis-(dppf)Pd(mu-trans-AZP)(4)(OTf)(8) (11), and cis-(dppf)Pd(mu-cis-AZP)(2)(OTf)(4) (12), where dppf is 1,1'-bis(diphenylphosphino)ferrocene and OTf is trifluoromethanesulfonate anion, were prepared by thermodynamically driven self-assembly processes. The photophysical and photochemical properties of these complexes have been investigated, and all of them show a lack of luminescence in room temperature solution. Upon irradiation at 313 or 366 nm, Pd(II)-Re(I)-containing tetranuclear squares 5, 8, and 11 undergo photoisomerization and convert to their corresponding dinuclear complexes 6, 9, and 12, whereas Pt(II)-Re(I)-based squares 7 and 10 show only slow square disassembling processes. The tetranuclear squares can be fully recovered by heating the photoisomerized solution for several hours.
Sun et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: